Therapeutic Advances in Drug Safety

Abuse potential of mirogabalin in recreational polydrug users

Educational intervention to improve the knowledge, attitude and practice of healthcare professionals regarding pharmacovigilance in South-South Nigeria

‘I think this medicine actually killed my wife’: patient and family perspectives on shared decision-making to optimize medications and safety

How Clinical Practice Research Datalink data are used to support pharmacovigilance

Precision dosing to avoid adverse drug reactions

Valsartan recall: global regulatory overview and future challenges

Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation

Prescribing issues in older adults living with HIV: thinking beyond drug–drug interactions with antiretroviral drugs

Frequency of undocumented medication discrepancies in discharge letters after hospitalization of older patients: a clinical record review study

Feasibility, acceptability and potential effectiveness of an information technology-based, pharmacist-led intervention to prevent an increase in anticholinergic and sedative load among older community-dwelling individuals

Evaluation of methenamine for urinary tract infection prevention in older adults: a review of the evidence

Pharmacist-assisted electronic prescribing at the time of admission to an inpatient orthopaedic unit and its impact on medication errors: a pre- and postintervention study

Benefit–risk evaluation: the past, present and future

Medication appropriateness criteria for older adults: a narrative review of criteria and supporting studies

Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial

Postmarket surveillance: a review on key aspects and measures on the effective functioning in the context of the United Kingdom and Canada

Teaching physicians the GPGP method promotes deprescribing in both inpatient and outpatient settings

Pharmacological effects and safety monitoring of anabolic androgenic steroid use: differing perceptions between users and healthcare professionals

Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance

Continuation of atypical antipsychotic medications in critically ill patients discharged from the hospital: a single-center retrospective analysis

Ceftolozane–tazobactam for the treatment of osteomyelitis caused by multidrug-resistant pathogens: a case series

Applicability of EU(7)-PIM criteria in cross-national studies in European countries

Bisphosphonates and cardiovascular risk in elderly patients with previous cardiovascular disease: a population-based nested case-control study in Italy

Evaluation of quantitative signal detection in EudraVigilance for orphan drugs: possible risk of false negatives

Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use

Patient-focused interventions to support vulnerable people using oral anticoagulants: a narrative review

Design and analysis of longitudinal trials of antimicrobial use at the end of life: to give or not to give?

A pilot cohort study of deprescribing for nursing home patients acutely admitted to hospital

Levetiracetam induced hypomania: a case report

Variability in the clinical management of iron deficiency anaemia in older adults: results from a survey of UK specialists in the care of older people

Metoclopramide as a prokinetic agent for diabetic gastroparesis: revisiting the risk of Parkinsonism

Fall-risk increasing drugs and recurrent injurious falls association in older patients after hip fracture: a cohort study protocol

Medication safety in emergency medical services: approaching an evidence-based method of verification to reduce errors

Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand

The impact of in hospital patient-education intervention on older people’s attitudes and intention to have their benzodiazepines deprescribed: a feasibility study

Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo

Effectiveness of the golimumab educational program in ensuring healthcare professionals’ awareness of risks described in the European risk management plan

Deferasirox in thalassemia: a comparative study between an innovator drug and its copy among a sample of Iraqi patients

Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand

Drug change: ‘a hassle like no other’. An in-depth investigation using the Danish patient safety database and focus group interviews with Danish hospital personnel

Safety evaluation of intravenous immunoglobulin in pediatric patients: a retrospective, 1-year observational study

Comparison of bleeding risks among non-vitamin K antagonist oral anticoagulants using the Korea adverse event reporting system database

Understanding adverse drug-related emergency department visits: development of a conceptual model through a systematic review

The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study

Pruritus after discontinuation of cetirizine

Effects of intravenous oxycodone alone or in combination with naltrexone on measures of respiratory depression: a randomized placebo-controlled study

The 3rd European Pharmacovigilance Congress: speaker abstracts